Coya Therapeutics, Inc
Advertisement
Coya Therapeutics, Inc. is a clinical-stage biotechnology company based in Houston, TX, focused on developing proprietary therapies to enhance the function of regulatory T cells. Their multi-modality Treg therapies are designed to address neurodegenerative, autoimmune, and metabolic diseases.
With strong proof of concept data in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's, Coya Therapeutics is dedicated to advancing their Treg Enhancing Biologics, including COYA 302 and COYA 301, as well as Allogeneic Treg Derived Exosomes (COYA 201) and Autologous Treg Cell Therapy (COYA 101). Their pipeline expansion includes the treatment of Frontotemporal Dementia and Parkinson's Disease, demonstrating their commitment to improving the lives of patients suffering from these debilitating conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement